• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[治疗浅表皮肤真菌病的新型抗真菌药物]

[New antifungal agents in the treatment of superficial dermatomycoses].

作者信息

Degreef H

机构信息

Université Catholique de Leuven, Hôpital Universitaire, Département de Dermatologie, Belgique.

出版信息

Ann Dermatol Venereol. 1993;120(1):21-31.

PMID:8393313
Abstract

New antifungals for topical and systemic treatment of superficial mycotic infections of the skin and nails have been developed in the last decade. Terconazole is a potent drug in treating topically vaginal candidiasis. Amorolfine belongs to the chemical class of morpholine derivatives and is topically active against a wide range of fungal infections. Also naftifine and terbinafine, two new allylamines, can be used in local therapy of superficial mycotic infections of the skin. Itraconazole and fluconazole are both new triazoles for systemic use. Itraconazole has a broader spectrum and a higher safety profile than ketoconazole, caused by a greater specificity for the fungal cytochrome P 450 14-alpha-demethylase. The pharmacokinetic properties result in shorter treatments, even in onychomycosis. The mode of action of fluconazole is the same as for the azoles. This drug was being studied particularly in systemic mycoses and mucosal candidiasis. The activity of orally terbinafine is directed mainly against dermatophytes. This drug offers new therapeutic possibilities in the treatment of onychomycosis, caused by dermatophytes.

摘要

在过去十年中,已开发出用于皮肤和指甲浅表真菌感染的局部和全身治疗的新型抗真菌药。特康唑是治疗局部阴道念珠菌病的有效药物。阿莫罗芬属于吗啉衍生物化学类别,对多种真菌感染具有局部活性。同样,萘替芬和特比萘芬这两种新型烯丙胺类药物可用于皮肤浅表真菌感染的局部治疗。伊曲康唑和氟康唑都是用于全身治疗的新型三唑类药物。由于对真菌细胞色素P 450 14-α-脱甲基酶具有更高的特异性,伊曲康唑比酮康唑具有更广泛的抗菌谱和更高的安全性。其药代动力学特性使得治疗时间缩短,即使在治疗甲癣时也是如此。氟康唑的作用方式与唑类相同。该药物尤其用于全身真菌病和黏膜念珠菌病的研究。口服特比萘芬的活性主要针对皮肤癣菌。该药物为皮肤癣菌引起的甲癣治疗提供了新的治疗可能性。

相似文献

1
[New antifungal agents in the treatment of superficial dermatomycoses].[治疗浅表皮肤真菌病的新型抗真菌药物]
Ann Dermatol Venereol. 1993;120(1):21-31.
2
Current concepts in systemic and topical therapy for superficial mycoses.浅部真菌病的系统和局部治疗的现代概念。
Clin Dermatol. 2010 Mar 4;28(2):212-6. doi: 10.1016/j.clindermatol.2009.12.016.
3
Antifungal agents: an overview. Part II.抗真菌药物:概述。第二部分。
J Am Acad Dermatol. 1994 Jun;30(6):911-33; quiz 934-6. doi: 10.1016/s0190-9622(94)70112-1.
4
New antifungal agents.新型抗真菌药物。
Dermatol Clin. 1992 Oct;10(4):799-805.
5
Current therapy of dermatophytosis.皮肤癣菌病的当前治疗方法。
J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S25-30. doi: 10.1016/s0190-9622(08)81263-7.
6
New and prospective developments in antifungal drugs.抗真菌药物的新进展与未来发展
Acta Derm Venereol Suppl (Stockh). 1986;121:147-53.
7
The use of systemic antimycotics in dermatotherapy.全身性抗真菌药在皮肤病治疗中的应用。
Eur J Dermatol. 2000 Mar;10(2):155-60.
8
Dermatophytosis: the management of fungal infections.皮肤癣菌病:真菌感染的管理
Skinmed. 2005 Sep-Oct;4(5):305-10. doi: 10.1111/j.1540-9740.2005.03435.x.
9
[Dermatomycoses: topical and systemic antifungal treatment].[皮肤真菌病:局部和全身抗真菌治疗]
Dermatologie (Heidelb). 2024 Aug;75(8):655-673. doi: 10.1007/s00105-024-05359-y. Epub 2024 Jun 14.
10
Terbinafine. An update of its use in superficial mycoses.特比萘芬。其在浅表真菌病治疗中的应用进展
Drugs. 1999 Jul;58(1):179-202. doi: 10.2165/00003495-199958010-00018.